Fragile-like regulatory T cells modulate opioid withdrawal in humans and mice
Marwa O Mikati1, Robyn S Klein2
1Center for Neuroimmunology & Neuroinfectious Diseases, St. Louis, MO, USA; Center for Clinical Pharmacology, University of Health Sciences and Pharmacy, St. Louis, MO, USA; Departments of Anesthesiology, Washington University School of Medicine, St. Louis, MO, USA.
Abstract:
Opioid use alters peripheral immune functions via unknown mechanisms. In a recent issue of Cell, Zhu et al. report increased fragile-like regulatory T cells in patients with opioid use disorder and in morphine-treated mice. In mice, Treg cell-derived interferon-γ within the brain promotes withdrawal-associated alterations in synapses.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
07:23Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
